Found 2031 results for "cancer"
Brain cancer patients face a fundamental therapeutic challenge: most promising drugs cannot cross the blood-brain barrier, leaving tumors essentially…
CAR T cell therapy for multiple myeloma has reached a critical juncture where understanding why some patients achieve durable remissions while others relapse…
A devastating discovery about childhood brain cancer reveals how the brain's own immune system becomes corrupted to fuel tumor spread. Diffuse midline glioma…
The fundamental promise of colorectal cancer screening—that early detection saves lives—faces scrutiny from a landmark Swedish trial challenging decades of…
Precision cancer treatment may advance significantly with the development of nanoscale drug carriers that simultaneously deliver chemotherapy and provide…
The assumption that cancer treatments only target tumor cells while leaving healthy tissue largely unscathed faces a significant challenge. This finding…
Chemical contamination from everyday products may be quietly undermining metabolic health in ways that predispose women to diabetes. This finding challenges…
Four plant compounds—curcumin, resveratrol, epigallocatechin gallate (EGCG), and genistein—demonstrate the ability to disrupt cancer stem cell (CSC) signaling…
Two sophisticated imaging technologies could fundamentally transform how physicians detect, stage, and treat advanced prostate cancer, potentially improving…
Pancreatic cancer's notorious resistance to treatment may finally face a formidable challenge. The disease kills roughly 50,000 Americans annually, with most…
Pancreatic cancer's notorious resistance to treatment may finally face a meaningful challenge. With five-year survival rates below 12%, this malignancy…
Triple-negative breast cancer represents one of the most aggressive malignancies, with limited treatment options and high metastatic potential that devastates…
Pancreatic ductal adenocarcinoma remains one of medicine's most formidable challenges, with five-year survival rates below 10% and limited therapeutic options…
Pancreatic cancer remains one of oncology's most formidable challenges, with five-year survival rates below 12% and limited treatment options once first-line…
The intersection of genetic risk factors may fundamentally alter how clinicians assess breast cancer susceptibility in men, particularly those developing the…
Chronic stress wreaks havoc on multiple body systems simultaneously, but medicine has lacked precise tools to measure this cumulative damage before diseases…
Glioblastoma represents medicine's most formidable oncological challenge, with median survival rarely exceeding 15 months despite aggressive treatment. The…
A comprehensive survey of 1,000 adults in Nouakchott, Mauritania's capital, reveals a concerning cancer risk landscape: 66.6% are overweight or obese, 58%…
Advanced prostate cancer treatment is shifting toward molecularly-guided therapy combinations that could dramatically improve survival outcomes for men with…
The persistence of aggressive breast cancer patterns in Black women demands urgent attention from both clinicians and patients navigating early detection…